Total raised
$55K
Stage
Pre-Funding
Founded
2015
Headcount
3
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
BrainFulness has developed a new technology for treating major depression, ADHD, and dementia - with NO SIDE EFFECTS! The company has built a working prototype of its technology and registered for patents in Israel, the United States, Germany, and Japan.
The prototype was approved for human use by the Israeli Health Ministry, and BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2C
Highlights
1 PatentsVerified
Tags
medical-devicesmental-healthpatientsnon-invasiveconsumers